Meridian Investment Counsel’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$951K Hold
9,195
0.2% 117
2026
Q1
$660K Hold
9,195
0.16% 134
2025
Q4
$730K Hold
9,195
0.18% 131
2025
Q3
$693K Sell
9,195
-2,189
-19% -$150K 0.17% 128
2025
Q2
$785K Hold
11,384
0.21% 113
2025
Q1
$771K Hold
11,384
0.23% 111
2024
Q4
$511K Sell
11,384
-2,398
-17% -$135K 0.15% 130
2024
Q3
$867K Sell
13,782
-2,299
-14% -$134K 0.26% 97
2024
Q2
$950K Sell
16,081
-950
-6% -$59.4K 0.3% 87
2024
Q1
$1.36M Sell
17,031
-333
-2% -$25.4K 0.45% 67
2023
Q4
$1.37M Buy
17,364
+2,225
+15% +$158K 0.47% 65
2023
Q3
$1.06M Sell
15,139
-200
-1% -$14.2K 0.4% 70
2023
Q2
$1.06M Hold
15,339
0.38% 74
2023
Q1
$1.14M Sell
15,339
-500
-3% -$41.9K 0.43% 64
2022
Q4
$1.48M Sell
15,839
-100
-0.6% -$9.65K 0.59% 53
2022
Q3
$1.52M Hold
15,939
0.68% 42
2022
Q2
$1.48M Hold
15,939
0.61% 48
2022
Q1
$1.61M Buy
15,939
+150
+1% +$15.8K 0.56% 52
2021
Q4
$1.63M Sell
15,789
-283
-2% -$26.2K 0.54% 50
2021
Q3
$1.36M Hold
16,072
0.49% 60
2021
Q2
$1.34M Hold
16,072
0.47% 65
2021
Q1
$1.21M Buy
16,072
+200
+1% +$14.6K 0.47% 59
2020
Q4
$1.08M Buy
15,872
+200
+1% +$13K 0.46% 60
2020
Q3
$915K Hold
15,672
0.44% 61
2020
Q2
$1.02M Buy
15,672
+12
+0.1% +$756 0.52% 54
2020
Q1
$929K Buy
15,660
+2,250
+17% +$150K 0.6% 54
2019
Q4
$996K Hold
13,410
0.49% 61
2019
Q3
$846K Buy
13,410
+50
+0.4% +$2.96K 0.46% 69
2019
Q2
$728K Buy
13,360
+100
+0.8% +$5.38K 0.4% 73
2019
Q1
$715K Buy
13,260
+665
+5% +$41K 0.42% 73
2018
Q4
$825K Buy
12,595
+640
+5% +$47.8K 0.54% 61
2018
Q3
$941K Buy
11,955
+300
+3% +$21.4K 0.51% 60
2018
Q2
$750K Hold
11,655
0.42% 74
2018
Q1
$725K Hold
11,655
0.41% 71
2017
Q4
$845K Sell
11,655
-500
-4% -$36.4K 0.46% 67
2017
Q3
$988K Hold
12,155
0.57% 56
2017
Q2
$978K Buy
12,155
+1,350
+12% +$107K 0.58% 59
2017
Q1
$848K Buy
10,805
+335
+3% +$26.7K 0.52% 64
2016
Q4
$826K Buy
10,470
+975
+10% +$78.9K 0.55% 59
2016
Q3
$845K Hold
9,495
0.57% 57
2016
Q2
$909K Hold
9,495
0.62% 52
2016
Q1
$985K Buy
9,495
+95
+1% +$9.24K 0.69% 47
2015
Q4
$919K Buy
9,400
+325
+4% +$31.8K 0.68% 50
2015
Q3
$876K Hold
9,075
0.72% 48
2015
Q2
$952K Sell
9,075
-300
-3% -$30.7K 0.68% 53
2015
Q1
$968K Sell
9,375
-200
-2% -$20.2K 0.67% 55
2014
Q4
$922K Hold
9,575
0.67% 52
2014
Q3
$762K Buy
9,575
+138
+1% +$10.9K 0.57% 56
2014
Q2
$711K Sell
9,437
-256
-3% -$19.3K 0.55% 64
2014
Q1
$726K Hold
9,693
0.62% 59
2013
Q4
$694K Buy
+9,693
New +$623K 0.59% 59

Other funds holding CVS

Meridian Investment Counsel's CVS Position: Q2 2026 in Review

Meridian Investment Counsel held its CVS Health (CVS) position steady in Q2 2026 at 9,195 shares worth $951K. The position accounts for 0.2% of the portfolio, ranked #117.

Meridian Investment Counsel first reported a position in CVS in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.63M in Q4 2021. 834 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Meridian Investment Counsel held 9,195 shares of CVS Health worth $951K as of Q2 2026.
  • Meridian Investment Counsel left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.2% of Meridian Investment Counsel's portfolio in Q2 2026, its #117 holding.
  • Meridian Investment Counsel first reported a position in CVS Health in Q4 2013 and has held it in 51 quarters since.
  • Meridian Investment Counsel's CVS Health position peaked at $1.63M in Q4 2021.
  • 834 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.